Safety and Immunogenicity of SARS-CoV-2 Recombinant Spike Protein Vaccine in Children and Adolescents in India

This phase 2-3 randomized clinical trial evaluates the noninferiority of SII-NVX-CoV2373 in children and adolescents compared with adults and the safety of SII-NVX-CoV2373 compared with placebo.
Source: JAMA Pediatrics - Category: Pediatrics Source Type: research